5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.04▼ | 3.04▼ | 3.04▼ | 3.13▼ | 3.03▼ |
MA10 | 3.11▼ | 3.11▼ | 3.11▼ | 3.22▼ | 3.10▼ |
MA20 | 3.19▼ | 3.20▼ | 3.19▼ | 3.13▼ | 3.15▼ |
MA50 | 3.17▼ | 3.15▼ | 3.23▼ | 3.05▼ | 3.46▼ |
MA100 | 3.13▼ | 3.22▼ | 3.13▼ | 3.24▼ | 2.17▲ |
MA200 | 3.27▼ | 3.20▼ | 3.27▼ | 3.37▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.027▼ | -0.028▼ | -0.026▼ | -0.018▼ | -0.013▼ |
RSI | 31.664▼ | 35.584▼ | 38.892▼ | 47.119▼ | 46.065▼ |
STOCH | 5.150▼ | 5.072▼ | 4.014▼ | 27.560 | 42.742 |
WILL %R | -91.667▼ | -94.203▼ | -94.203▼ | -82.143▼ | -68.862 |
CCI | -81.907 | -81.442 | -81.181 | -49.369 | -21.684 |
Wednesday, June 04, 2025 10:41 AM
Eyenovia (NASDAQ: EYEN) Extends Betaliq Merger Talks its exclusivity period to finalize a merger with Betaliq, a clinical-stage glaucoma-focused company. The deal would unite Betaliq's Eyesol® ...
|
Wednesday, June 04, 2025 10:41 AM
Eyenovia (NASDAQ: EYEN) Extends Betaliq Merger Talks its exclusivity period to finalize a merger with Betaliq, a clinical-stage glaucoma-focused company. The deal would unite Betaliq's Eyesol® ...
|
Tuesday, June 03, 2025 06:17 PM
Here Are Other Stocks Moving In Friday's Mid-Day Session Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarter financial ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 3.015 | 3.03 | 3.015 | 3.03 | 11,133 |
13/06/25 | 2.99 | 3.17 | 2.99 | 3.02 | 35,800 |
12/06/25 | 3.18 | 3.18 | 2.94 | 3.08 | 71,500 |
11/06/25 | 3.34 | 3.34 | 3.16 | 3.16 | 85,100 |
10/06/25 | 3.215 | 3.355 | 3.21 | 3.355 | 91,721 |
09/06/25 | 3.05 | 3.28 | 3.00 | 3.25 | 141,900 |
06/06/25 | 3.04 | 3.21 | 2.78 | 3.08 | 229,800 |
05/06/25 | 3.04 | 3.30 | 2.90 | 3.09 | 351,200 |
04/06/25 | 3.78 | 3.78 | 2.97 | 3.19 | 754,100 |
03/06/25 | 3.96 | 4.18 | 3.31 | 3.90 | 24,503,529 |
|
|
||||
|
|
||||
|
|